Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab
- PMID: 33016326
- DOI: 10.1093/ecco-jcc/jjaa202
Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab
Comment on
-
Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.J Crohns Colitis. 2021 Jan 13;15(1):162-164. doi: 10.1093/ecco-jcc/jjaa115. J Crohns Colitis. 2021. PMID: 32588044 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
